RAB8A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.006200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.023000E-01
Normal-vs-Stage2
6.883400E-01
Normal-vs-Stage3
5.339200E-01
Normal-vs-Stage4
2.016200E-01
Stage1-vs-Stage2
1.903390E-01
Stage1-vs-Stage3
8.782000E-01
Stage1-vs-Stage4
9.960000E-01
Stage2-vs-Stage3
4.086000E-01
Stage2-vs-Stage4
2.792400E-01
Stage3-vs-Stage4
8.928400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.467200E-01
Normal-vs-AfricanAmerican
5.998600E-01
Normal-vs-Asian
8.834000E-01
Caucasian-vs-AfricanAmerican
9.743200E-01
Caucasian-vs-Asian
1.555840E-01
AfricanAmerican-vs-Asian
4.054600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.150000E-01
Normal-vs-Female
5.643000E-01
Male-vs-Female
8.995800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.119600E-01
Normal-vs-Age(41-60Yrs)
7.995600E-01
Normal-vs-Age(61-80Yrs)
5.076400E-01
Normal-vs-Age(81-100Yrs)
6.598800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.886400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.257000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.447000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.133210E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.909600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.459200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.405600E-01
Normal-vs-Daily Drinker
6.949800E-01
Normal-vs-Weekly Drinker
7.856400E-01
Normal-vs-Occasional Drinker
5.712800E-01
Normal-vs-Social Drinker
4.676800E-01
Non Drinker-vs-Daily Drinker
7.473400E-01
Non Drinker-vs-Weekly Drinker
5.401800E-01
Non Drinker-vs-Occasional Drinker
7.925600E-01
Non Drinker-vs-Social Drinker
8.353800E-01
Daily Drinker-vs-Weekly Drinker
7.830200E-01
Daily Drinker-vs-Occasional Drinker
9.445400E-01
Daily Drinker-vs-Social Drinker
9.005600E-01
Weekly Drinker-vs-Occasional Drinker
6.998800E-01
Weekly Drinker-vs-Social Drinker
6.547000E-01
Occasional Drinker-vs-Social Drinker
9.560400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.317390E-01
Normal-vs-Grade 2
3.842000E-01
Normal-vs-Grade 3
2.279800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.500900E-03
Grade 1-vs-Grade 3
1.864380E-02
Grade 1-vs-Grade 4
1.317390E-01
Grade 2-vs-Grade 3
8.938200E-01
Grade 2-vs-Grade 4
3.842000E-01
Grade 3-vs-Grade 4
2.279800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.647000E-01
Normal-vs-NonDiabetic
6.182200E-01
Diabetic-vs-NonDiabetic
5.748400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.964000E-01
Normal-vs-NoPancreatitis
5.250600E-01
Pancreatitis-vs-NoPancreatitis
2.184000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.556800E-01
Normal-vs-N1
6.483800E-01
N0-vs-N1
8.525800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.589600E-01
Normal-vs-TP53-NonMutant
3.085800E-01
TP53-Mutant-vs-TP53-NonMutant
9.164000E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
